Boardroom Alpha
Start trial
Boardroom Alpha
KEQU · Additional Proxy Materials (DEFA14A) · Filed July 7, 2026

Kewaunee Scientific Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
July 7, 2026
Ticker
KEQU
Accession
0001140361-26-027714
Kewaunee Scientific Corp on Boardroom AlphaView on SEC EDGAR
Boardroom Alpha · Filing insights

Kewaunee Scientific’s board urges votes for Pyle and Shaw, and to ratify Forvis Mazars, LLP and approve Say-on-Pay.

About Kewaunee Scientific Corp
Market cap
$108M
1Y TSR
−34.4%
3Y TSR
+33.7%
Board grade
B+
Sector
Consumer Cyclical
CEO
Thomas David Hull III
Last annual meeting: Aug 26, 2026 · View full Kewaunee Scientific Corp profile →
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 14A
(RULE 14a-101)
SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Amendment No.   )

Filed by the registrant ☒
Filed by a party other than the registrant ☐
Check the appropriate box:
☐
Preliminary proxy statement.
 ☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive proxy statement.
☒
Definitive additional materials.
☐
Soliciting Material under §240.14a-12.

Kewaunee Scientific Corporation
(Name of Registrant as Specified in Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):
☒
No fee required.
☐
Fee paid previously with preliminary materials.
☐
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
 Your Vote Counts!  KEWAUNEE SCIENTIFIC CORPORATION ATTN: THOMAS D. HULL III  P.O. BOX 1842  STATESVILLE, NC 28687-1842  KEWAUNEE SCIENTIFIC CORPORATION  2025 Annual Meeting  Vote by August 26, 2025  11:59 PM ET  You invested in KEWAUNEE SCIENTIFIC CORPORATION and it’s time to vote!  You have the right to vote on proposals being presented at the Annual Meeting. Important Notice Regarding the Availability of  Proxy Materials for the Stockholder Meeting To Be Held on August 27, 2025.  Get informed before you vote  View the Notice and Proxy Statement and Form 10-K online OR you can receive a free paper or email copy of the material(s) by  requesting prior to August 13, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.  Vote Virtually at the Meeting*  August 27, 2025  11:00 AM Eastern Time  Virtually at: www.virtualshareholdermeeting.com/KEQU2025  *Please check the meeting materials for any special requirements for meeting attendance.  Smartphone users  Point your camera here and vote without entering a control number  For complete information and to vote, visit www.ProxyVote.com  Control #  V75931-P34987 
 
 Vote at www.ProxyVote.com  THIS IS NOT A VOTABLE BALLOT  This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.  Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.  1. Election of Directors - Class III  For  1a. Margaret B. Pyle  1b. Donald F. Shaw  For  2. Ratification of the appointment of the independent registered public accounting firm of Forvis Mazars, LLP as the Company’s independent auditors for fiscal year 2026.  For  3. Approval, on an advisory basis, of the compensation of our named executives.  For  NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the Annual Meeting and any postponement or adjournment thereof.  Voting Items  Board Recommends  V75932-P34987 
 
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

See Meeting ForecastSchedule a Demo

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Kewaunee Scientific Corp (KEQU)

Continue researching
Reference

Frequently asked questions

When did Kewaunee Scientific Corp file this DEFA14A?
Kewaunee Scientific Corp (KEQU) filed this Additional Proxy Materials (DEFA14A) with the SEC on July 7, 2026. The accession number assigned by EDGAR is 0001140361-26-027714.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Kewaunee Scientific’s board urges votes for Pyle and Shaw, and to ratify Forvis Mazars, LLP and approve Say-on-Pay. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Kewaunee Scientific Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Kewaunee Scientific Corp has filed under CIK 55529, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer